Gulf & Pacific Equities Corp. reports on Third Quarter Results with Revenue of $1,134,846

Toronto, ON, Nov. 21, 2025 (GLOBE NEWSWIRE) — Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on the acquisition, management and development of anchored shopping centers in Western Canada, reports a 3. 0% decrease in revenues to $1,134,846 in the quarter ended September 30, 2025, from $1,169,849 at the same period last year. Details of the nine and three months financial results for fiscal 2025 and 2024 under International Financial Reporting Standards (IFRS), as summarized below, are also available at www. sedar release contains “forward-looking statements”, within the meaning of the United States Private Securities Litigation Reform Act of 1995 and similar Canadian legislation, concerning the business, operations and financial performance and condition of Gulf & Pacific Equities. Forward-looking statements include, but are not limited to, statements with respect to the benefits of the offering and option transaction. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “plansexpects” or “does not expectis expectedbudgetscheduledestimatesforecastsintendsanticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “maycouldwouldmight” or “will be takenoccur” or “be achieved”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Gulf & Pacific Equities to be materially different from those expressed or implied by such forward-looking statements, including but not limited to risks related to: economic conditions in Western Canada, interest rates, raising less than the required capital; not realizing on the anticipated benefits from the transaction or not realizing on such anticipated benefits within the expected time frame; and other risks of the real estate industry. Although management of Gulf & Pacific Equities has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Gulf & Pacific Equities does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws.
https://www.globenewswire.com/news-release/2025/11/21/3192710/0/en/Gulf-Pacific-Equities-Corp-reports-on-Third-Quarter-Results-with-Revenue-of-1-134-846.html

Full Truck Alliance Co. Ltd. (YMM) Q3 2025 Earnings Call Transcript

Mao Mao Head of Investor Relations Thank you, operator. Please note that today’s discussion will contain forward-looking statements relating to the company’s future performance, which are intended to qualify for the safe harbor from liability as established by the U. S. Private Securities Litigation Reform Act. Such statements are not guarantees of future performance and are subject to certain risks and uncertainties, assumptions and other factors. Some of these risks are beyond the company’s control and could cause actual results to differ materially from those mentioned in today’s press release and discussion. A general discussion of the risk factors that could affect FTA’s business and financial results is included in certain filings of the company with the SEC. The company does not undertake any obligation to update this forward-looking information, except as required by law. During today’s call, management will also discuss certain non-GAAP financial measures for comparison purpose only. For a definition of non-GAAP financial measures and a reconciliation of GAAP to non-GAAP financial results, please see the earnings release issued earlier today.
https://seekingalpha.com/article/4844576-full-truck-alliance-co-ltd-ymm-q3-2025-earnings-call-transcript?source=feed_all_articles

COSCIENS Biopharma Inc. Announces Leadership Change

TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, announced today that Peter H. Puccetti, CFA, Chairman of the Company’s board of directors (the “Board”), has been appointed Interim Chief Executive Officer, effective immediately.

Peter succeeds Anna Biehn, who has stepped down as Chief Executive Officer.

“As the Company continues its efforts to reduce costs and streamline its organizational structure while aligning resources with key strategic priorities, the Board has determined that now is the right time to transition leadership,” said Robert Seager, Chair of the Human Resources, Nominating and Governance Committee.

“Peter is already deeply involved in driving the strategic reorientation of the Company and has a proven track record of creating value with similarly situated businesses. We are confident that the Company will be well-served by Peter’s leadership at this critical juncture.”

Mr. Puccetti said, “In my expanded role as Chairman and Interim CEO, I plan on continuing to strengthen operational performance, while working to create the conditions necessary for driving shareholder value.”

He added, “On behalf of everyone at COSCIENS, I want to thank Anna for her professionalism, leadership, and contributions. We wish her all the best in her future endeavors.”

### About COSCIENS Biopharma Inc.

COSCIENS is a life science company with a diverse portfolio focused on the development of natural, plant-based active ingredients and engaged in the commercialization of pharmaceutical and diagnostic products.

COSCIENS’ natural active ingredient business leverages the Company’s proprietary manufacturing and extraction technologies to develop Avenanthramides and Beta Glucan active ingredients currently used in leading skincare brands worldwide.

COSCIENS’ lead pharmaceutical product Macimorelin (Macrilen; Ghryvelin) is the first and only U.S. Food and Drug Administration (“FDA”) and European Medicines Agency (“EMA”) approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

The Company’s common shares are listed on the Toronto Stock Exchange (“TSX”) under the symbol “CSCI.” The Company’s common shares were assigned the trading symbol “CSCIF” by FINRA’s Department of Market Operations for quoting and trading in the market for unlisted securities (i.e., the “over-the-counter market” or “OTC” market) in the United States as of September 4, 2025.

For more information, please visit COSCIENS’ website at [www.cosciensbio.com](http://www.cosciensbio.com).

### Forward-Looking Statements

Certain statements in this news release, referred to herein as “forward-looking statements,” constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended, and “forward-looking information” under the provisions of Canadian securities laws.

All statements, other than statements of historical fact, that address circumstances, events, activities, or developments that could or may or will occur are forward-looking statements.

When used in this release, words such as “anticipate,” “assume,” “believe,” “could,” “expect,” “forecast,” “future,” “goal,” “guidance,” “intend,” “likely,” “may,” “would,” or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are generally intended to identify forward-looking statements, although not all forward-looking statements include such words.

Forward-looking statements in this news release include, but are not limited to, statements relating to the expectations of the Interim Chief Executive Officer. These statements are based on current expectations and assumptions, including factors or assumptions applied in drawing conclusions or making forecasts or projections, based on historical trends, current conditions, and expected future developments.

Since forward-looking statements relate to future events and conditions, by their very nature they require making assumptions and involve inherent risks and uncertainties.

The Company cautions that although it is believed that the assumptions are reasonable in the circumstances, these risks and uncertainties give rise to the possibility that actual results may differ materially from those expressed or implied by such forward-looking statements, including but not limited to the factors described in “Risks Relating to Us and Our Business” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024.

Given these risks, undue reliance should not be placed on these forward-looking statements, which apply only as of their dates.

The Company disclaims any obligation to update any such risks or uncertainties or to publicly announce any revisions to any of the forward-looking statements contained herein to reflect future results, events, or developments, unless required to do so by a governmental authority or applicable law.

### Issuer Contact:

**Peter H. Puccetti**
Interim CEO and Chairman of the Board
pp@cosciensbio.com

**Giuliano La Fratta**
Chief Financial Officer
glafratta@cosciensbio.com

### Investor Contact:

IR@cosciensbio.com
https://www.globenewswire.com/news-release/2025/11/14/3188655/0/en/COSCIENS-Biopharma-Inc-Announces-Leadership-Change.html

Global Crossing Airlines Group Inc. (JET:CA) Q3 2025 Earnings Call Transcript

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to today’s conference call to discuss Global Crossing Airlines’ financial results for the third quarter of 2025.

As a reminder, this conference call is being recorded. Joining us on the call today are the company’s Executive Chairman, Chris Jamroz; President and CFO, Ryan Goepel; and SVP, Corporate Controller, Wendy Shapiro.

Please note that this conference call will contain statements that are considered forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these statements. Additional risks and uncertainties are described from time to time in the company’s filings with the SEC.

We caution you not to place undue reliance on any forward-looking statements, which are being made only as of the date of this call. Except as required by law, the company undertakes no obligation to publicly update or revise any forward-looking statements. For important risks and assumptions associated with such statements, please refer to the company’s earnings press release for the third quarter of 2025 and the company’s annual report on Form 10-K for the year ended December 31, 2024.

Additionally, the company’s presentation includes certain non-GAAP financial measures, including EBITDA and EBITDAR, as supplemental measures of business performance. All non-GAAP measures have been reconciled to their most directly comparable GAAP measures.
https://seekingalpha.com/article/4839387-global-crossing-airlines-group-inc-jet-ca-q3-2025-earnings-call-transcript?source=feed_all_articles